What Has Been the Growth Trajectory for the ADME Toxicology Testing Market in Recent Years?
The adme toxicology testing market has seen considerable growth due to a variety of factors.
•In recent times, the ADME toxicology testing market has seen swift growth. The market size is anticipated to escalate from $10.4 billion in 2024 to approximately $11.53 billion in 2025, at a compound annual growth rate (CAGR) of 10.8%.
The surge observed in the historic phase can be accredited to rigorous regulatory norms, elevated activities in drug development, increasing apprehensions regarding drug safety, enhancements in in vitro testing procedures, and augmented outsourcing of toxicology research.
How Does the Forecast Look for the ADME Toxicology Testing Market?
The adme toxicology testing market is expected to maintain its strong growth trajectory in upcoming years.
• Anticipation surrounds the ADME toxicology testing market as it is predicted to experience significant expansion in the coming years. By 2029, the market is projected to reach $18.06 billion, with an impressive compound annual growth rate (CAGR) of 11.9%.
The forecasted growth within this period can be credited to the swift growth of biopharmaceuticals, the increasing focus on personalized medicine, the emergence of advanced therapies, the improvement of predictive toxicology models, and the worldwide rise in chemical safety testing. The major trends anticipated during this forecast period are the expansion of biomarker applications, the integration of multi-omics data, regulators' focus on in vitro testing, evolution of collaborations and partnerships, and the ongoing advancements in technology.
What Are the Critical Driver Fuelling the ADME Toxicology Testing Market's Growth?
The surge in need for innovative medications is predicted to boost the ADME toxicology testing market's expansion in the future. These innovative drugs are pharmaceutical compounds that have not been previously sanctioned or marketed for therapeutic application. Conducting ADME toxicity tests is a crucial phase in the development of new drugs to confirm the drug's safety and its non-production of harmful toxins in the human body. For instance, in January 2024, the Center for Drug Evaluation and Research (CDER), a US-based division of the U.S. Food and Drug Administration (FDA), authenticated the approval of 55 innovative drugs in 2023 showcased in the New Drug Therapy Approvals 2023 report. Out of these, 20 or 36% are identified as first-of-their-kind, in contrast to the approval of 37 unique drugs in 2022. Because of this, the increasing need for innovative medicines is fuelling ADME toxicology testing market's growth.
How Is the ADME Toxicology Testing Market segmented?
The ADME toxicology testing market covered in this report is segmented –
1) By Product Type: Instruments, Software Solutions, Assays Systems, Reagents, Other Products
2) By Method: Cellular Assay, Biochemical Assay, In Silica, Ex-Vivo
3) By Technology: Cell Culture, High Throughput, Molecular Imaging, OMICS Technology, Other Technologies
4) By Application: Systemic Toxicity, Renal Toxicity, Hepatotoxicity, Neurotoxicity, Other Applications
5) By End-User: Cosmetics And Household Products, Pharmaceutical Industry, Animal Industry, Food Industry, Other End Users
Subsegments:
1) By Instruments: High-Throughput Screening Instruments, LC-MS Or MS (Liquid Chromatography-Mass Spectrometry), HPLC (High-Performance Liquid Chromatography), Automated Workstations
2) By Software Solutions: Data Management Software, Simulation And Modeling Software, Risk Assessment Software
3) By Assay Systems: Cell-Based Assays, In Vitro Assays, Bioanalytical Assays
4) By Reagents: Biochemicals, Buffer Solutions, Culture Media
5) By Other Products: Kits And Consumables, Analytical Standards
Pre-Book The ADME Toxicology Testing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing the ADME Toxicology Testing Market?
The rise in technological developments is becoming a primary trend in the ADME toxicology testing market. Large corporations involved in the ADME toxicology testing industry are offering creative assay solutions using advanced technologies like Logica to maintain their market share. For example, in April 2022, US-based pharmaceutical firm Charles River Laboratories International Inc. and Valo Health Inc., an American AI-health solution firm, released Logica, a drug development solution based on AI. This innovative solution uses Valo’s AI-backed Opal Computational Platform to offer ADME toxicology testing services along with other drug delivery systems.
Who Are the Key Players in the ADME Toxicology Testing Market?
Major companies operating in the ADME toxicology testing market include:
• AbbVie Inc.
• Thermo Fisher Scientific Inc.
• Boehringer Ingelheim GmbH
• Laboratory Corporation of America Holdings
• Corning Incorporated
• Eurofins Scientific SE
• Agilent Technologies Inc.
• Lonza Group AG
• Dassault Systèmes SE
• Catalent Inc.
• Charles River Laboratories International Inc.
• Beckman Coulter Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Curia Global Inc
• Promega Corporation
• Takara Bio Inc
• AB Sciex LLC
• QPS Holdings LLC
• Simulations Plus Inc.
• Cyprotex
• XenoTech LLC
• BioIVT LLC
• Absorption Systems
• Creative Bioarray
• SOLVO Biotechnology Rt.
• Creative Biolabs Inc
• Gentronix Limited
• Admecell Inc.
• Molecular Discovery Ltd.
What Is The Most Dominant Region In The ADME Toxicology Testing Market?
North America was the largest region in the ADME toxicology testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ADME toxicology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
